{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:57:23Z","timestamp":1773262643384,"version":"3.50.1"},"reference-count":100,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Children\u2019s Hospital of Eastern Ontario, Ottawa, Ontario","award":["2096"],"award-info":[{"award-number":["2096"]}]},{"name":"Natural Science Foundation of Hubei Province for Hubei University of Technology","award":["2096"],"award-info":[{"award-number":["2096"]}]},{"name":"\u00d6sterreichische Krebshilfe Tyrol","award":["2096"],"award-info":[{"award-number":["2096"]}]},{"name":"Austrian Research Fund","award":["2096"],"award-info":[{"award-number":["2096"]}]},{"name":"Cancer Research Society","award":["2096"],"award-info":[{"award-number":["2096"]}]},{"name":"Canadian Institutes of Health Research","award":["2096"],"award-info":[{"award-number":["2096"]}]},{"name":"Saudi Cultural Bureau, Ottawa, Canada","award":["2096"],"award-info":[{"award-number":["2096"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inheritable disease of cystic degeneration in the kidney. ADPKD is a significant cause of end-stage renal disease (ESRD). Autosomal Dominant Polycystic Liver Disease (ADPLD) results in substantial PLD with minimal PKD. Currently, there are eight genes which have been associated with ADPKD (PKD1 and PKD2), ADPLD (PRKCSH, SEC63, LRP5, ALG8, and SEC61B), or both (GANAB). The severity of ADPKD can show an extremely broad range, but the evolution to ESRD is doubtless unavoidable. In some patients, carcinogenesis develops with inflammation as a potential promoting factor. In this chapter, we illustrate the severity of ADPKD and the fate to develop renal cell carcinoma (RCC).<\/jats:p>","DOI":"10.3390\/ijms26093965","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T03:43:37Z","timestamp":1745379817000},"page":"3965","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Autosomal Dominant Polycystic Kidney Disease-Related Multifocal Renal Cell Carcinoma: A Narrative Iconographic Review"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2779-7879","authenticated-orcid":false,"given":"Consolato M.","family":"Sergi","sequence":"first","affiliation":[{"name":"Anatomic Pathology, Children\u2019s Hospital of Eastern Ontario (CHEO), University of Ottawa, Ottawa, ON K1H 8L1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Guerra","sequence":"additional","affiliation":[{"name":"Pediatric Urology, Children\u2019s Hospital of Eastern Ontario (CHEO), University of Ottawa, Ottawa, ON K1H 8L1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Hager","sequence":"additional","affiliation":[{"name":"Pediatric Surgery, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sergi, C. (2020). Pathology of Childhood and Adolescence, Springer. [1st ed.].","DOI":"10.1007\/978-3-662-59169-7"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.40.5.311","article-title":"Molecular pathology and genetics of congenital hepatorenal fibrocystic syndromes","volume":"40","author":"Johnson","year":"2003","journal-title":"J. Med. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13023-020-01585-4","article-title":"Novel GANAB variants associated with polycystic liver disease","volume":"15","author":"Hoischen","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"146313","DOI":"10.1016\/j.gene.2022.146313","article-title":"Polycystin-2 (TRPP2): Ion channel properties and regulation","volume":"827","author":"Cantero","year":"2022","journal-title":"Gene"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1001\/jama.2022.22847","article-title":"Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease","volume":"328","author":"Chang","year":"2022","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.kint.2021.10.014","article-title":"\u201cADPKD-omics\u201d: Determinants of cyclic AMP levels in renal epithelial cells","volume":"101","author":"Mehta","year":"2022","journal-title":"Kidney Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Alam","year":"2019","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109568","DOI":"10.1016\/j.cellsig.2020.109568","article-title":"Role of transcription factor hepatocyte nuclear factor-1beta in polycystic kidney disease","volume":"71","author":"Shao","year":"2020","journal-title":"Cell Signal."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00467-021-04974-4","article-title":"The wind of change in the management of autosomal dominant polycystic kidney disease in childhood","volume":"37","author":"Gimpel","year":"2022","journal-title":"Pediatr. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40348-021-00131-x","article-title":"Translational research approaches to study pediatric polycystic kidney disease","volume":"8","author":"Liebau","year":"2021","journal-title":"Mol. Cell Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nefro.2021.05.009","article-title":"Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020","volume":"42","author":"Ars","year":"2022","journal-title":"Nefrologia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40620-021-01062-6","article-title":"Therapeutic advances in ADPKD: The future awaits","volume":"35","author":"Capuano","year":"2022","journal-title":"J. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yu, Z., Shen, X., Hu, C., Zeng, J., Wang, A., and Chen, J. (2022). Molecular Mechanisms of Isolated Polycystic Liver Diseases. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.846877"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2215\/CJN.02320220","article-title":"Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies","volume":"16","author":"Lanktree","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.21873\/cgp.20363","article-title":"Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers","volume":"20","author":"Meguro","year":"2023","journal-title":"Cancer Genom. Proteom."},{"key":"ref_16","first-page":"e22659","article-title":"Delayed Metastasis of Clear Cell Renal Carcinoma to the Colon in the Setting of Benign Kidney Disease","volume":"14","author":"Tagliaferri","year":"2022","journal-title":"Cureus"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhang, X., and Li, X. (2022). Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential. Metabolites, 12.","DOI":"10.3390\/metabo12010058"},{"key":"ref_18","unstructured":"Costa, E., Giuliani, A., Corradi, V., Caprara, C., Rigato, M., Milan Manani, S., Tantillo, I., Ronco, C., Gastaldon, F., and Zanella, M. (2022). Lymphocytic leukopenia in two patients affected by polycystic kidney disease waiting for renal transplantation. G Ital. Nefrol., 39, Available online: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35470994."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.ekir.2022.08.012","article-title":"Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD","volume":"7","author":"Econimo","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3892\/mco.2021.2386","article-title":"Incidental occurrence of papillary renal cell carcinoma in the native kidney with autosomal dominant polycystic kidney disease after renal transplantation: A case report","volume":"15","author":"Abbas","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13730-020-00544-z","article-title":"Sarcomatoid renal cell carcinoma with autosomal dominant polycystic kidney disease: A case report and literature review","volume":"10","author":"Hakozaki","year":"2021","journal-title":"CEN Case Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Millet-Boureima, C., He, S., Le, T.B.U., and Gamberi, C. (2021). Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083918"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pagliarini, R., and Podrini, C. (2021). Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD. Front. Med., 8.","DOI":"10.3389\/fmed.2021.740087"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Santoni, M., Piva, F., Cimadamore, A., Giulietti, M., Battelli, N., Montironi, R., Cosmai, L., and Porta, C. (2020). Exploring the Spectrum of Kidney Ciliopathies. Diagnostics, 10.","DOI":"10.3390\/diagnostics10121099"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e20071","DOI":"10.1097\/MD.0000000000020071","article-title":"Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient","volume":"99","author":"Shim","year":"2020","journal-title":"Medicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"109495","DOI":"10.1016\/j.cellsig.2019.109495","article-title":"Metabolic reprogramming and the role of mitochondria in polycystic kidney disease","volume":"67","author":"Podrini","year":"2020","journal-title":"Cell Signal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.21037\/tau.2018.07.12","article-title":"Transplant immunosuppressive drugs in urology","volume":"8","author":"Crane","year":"2019","journal-title":"Transl. Androl. Urol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"F1855","DOI":"10.1152\/ajprenal.00025.2018","article-title":"Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis","volume":"315","author":"Trott","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4103\/IJPM.IJPM_357_16","article-title":"Multicentric papillary and chromophobe renal cell carcinomas in a patient with autosomal dominant polycystic kidney disease: Report of a rare case","volume":"60","author":"Sahoo","year":"2017","journal-title":"Indian. J. Pathol. Microbiol."},{"key":"ref_30","first-page":"313","article-title":"A Case of Autosomal Dominant Polycystic Kidney Disease (ADPKD) with Metastases from Bilateral Small Renal Cell Carcinoma","volume":"62","author":"Nezu","year":"2016","journal-title":"Hinyokika Kiyo."},{"key":"ref_31","first-page":"EC08","article-title":"Histopathologic Findings in Autopsies with Emphasis on Interesting and Incidental Findings-A Pathologist\u2019s Perspective","volume":"10","author":"Patel","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12957-016-0916-3","article-title":"Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease","volume":"14","author":"Xu","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cancergen.2015.11.002","article-title":"Papillary renal cell carcinoma with a somatic mutation in MET in a patient with autosomal dominant polycystic kidney disease","volume":"209","author":"Zhang","year":"2016","journal-title":"Cancer Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3892\/ol.2014.2469","article-title":"Erythropoietin production in renal cell carcinoma and renal cysts in autosomal dominant polycystic kidney disease in a chronic dialysis patient with polycythemia: A case report","volume":"8","author":"Ito","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000351049","article-title":"Autosomal dominant polycystic kidney disease: Prevalence of renal neoplasias in surgical kidney specimens","volume":"123","author":"Jilg","year":"2013","journal-title":"Nephron Clin. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4132\/KoreanJPathol.2012.46.4.382","article-title":"Multifocal renal cell carcinoma of different histological subtypes in autosomal dominant polycystic kidney disease","volume":"46","author":"Na","year":"2012","journal-title":"Korean J. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1308\/003588411X582690","article-title":"Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease","volume":"93","author":"Patel","year":"2011","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","article-title":"Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure","volume":"74","author":"Hajj","year":"2009","journal-title":"Urology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1726-4901(08)70029-7","article-title":"Bilateral renal cell carcinoma in a patient with autosomal dominant polycystic kidney disease","volume":"70","author":"Chang","year":"2007","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1259\/bjr\/28214940","article-title":"Erythropoietin-producing renal cell carcinoma arising from autosomal dominant polycystic kidney disease","volume":"78","author":"Hama","year":"2005","journal-title":"Br. J. Radiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","article-title":"Polycystic kidney disease: Neoplasia in disguise","volume":"15","author":"Grantham","year":"1990","journal-title":"Am. J. Kidney Diseases."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Renda, A., de Werra, C., Donzelli, I., Perone, M., Micco, R.D., and Orabona, G. (2009). Multifocal and multicentric tumors. Multiple Primary Malignancies, Springer.","DOI":"10.1007\/978-88-470-1095-6_9"},{"key":"ref_43","first-page":"1","article-title":"Development of acquired cystic disease and adenocarcinoma of the kidney in glomerulonephritic chronic hemodialysis patients","volume":"14","author":"Ishikawa","year":"1980","journal-title":"Clin. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.celrep.2017.02.074","article-title":"The SWI\/SNF protein PBRM1 restrains VHL-loss-driven clear cell renal cell carcinoma","volume":"18","author":"Nargund","year":"2017","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1537709","DOI":"10.1080\/23723556.2018.1537709","article-title":"mTORC1-driven accumulation of the oncometabolite fumarate as a potential critical step in renal cancer progression","volume":"6","author":"Drusian","year":"2019","journal-title":"Mol. Cell. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ki.1997.3","article-title":"Renal cysts, renal cancer and von Hippel-Lindau disease","volume":"51","author":"Neumann","year":"1997","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"109624","DOI":"10.1016\/j.cellsig.2020.109624","article-title":"Endothelial-epithelial communication in polycystic kidney disease: Role of vascular endothelial growth factor signalling","volume":"72","author":"Jafree","year":"2020","journal-title":"Cell Signal."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-012-2305-7","article-title":"Angiogenesis and autosomal dominant polycystic kidney disease","volume":"28","author":"Huang","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1681\/ASN.2014090856","article-title":"Vascular endothelial growth factor C for polycystic kidney diseases","volume":"27","author":"Huang","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"F1145","DOI":"10.1152\/ajprenal.00337.2017","article-title":"In vivo three-dimensional photoacoustic imaging of the renal vasculature in preclinical rodent models","volume":"314","author":"Ogunlade","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nm.2545","article-title":"The lymphatic vasculature in disease","volume":"17","author":"Alitalo","year":"2011","journal-title":"Nat. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e48183","DOI":"10.7554\/eLife.48183","article-title":"Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease","volume":"8","author":"Jafree","year":"2019","journal-title":"Elife"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sergi, C. (2019). EPAS 1, congenital heart disease, and high altitude: Disclosures by genetics, bioinformatics, and experimental embryology. Biosci. Rep., 39.","DOI":"10.1042\/BSR20182197"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"77591","DOI":"10.18632\/oncotarget.12728","article-title":"Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma","volume":"7","author":"Hagenbuchner","year":"2016","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MPG.0b013e31824b6391","article-title":"Angiogenic remodeling in pediatric EoE is associated with increased levels of VEGF-A, angiogenin, IL-8, and activation of the TNF-alpha-NFkappaB pathway","volume":"55","author":"Persad","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1681\/ASN.2014010060","article-title":"Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney","volume":"26","author":"Dimke","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ajh.21745","article-title":"Pericytes and vessel maturation during tumor angiogenesis and metastasis","volume":"85","author":"Raza","year":"2010","journal-title":"Am. J. Hematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.24238","article-title":"Complexity of tumor vasculature in clear cell renal cell carcinoma","volume":"115","author":"Qian","year":"2009","journal-title":"Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41379-019-0214-z","article-title":"Specific immune cell and lymphatic vessel signatures identified by image analysis in renal cancer","volume":"32","author":"Schraml","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","volume":"14","author":"Chen","year":"2016","journal-title":"Cell Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/(SICI)1098-2264(199909)26:1<20::AID-GCC3>3.0.CO;2-6","article-title":"Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development","volume":"26","author":"Clifford","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"109524","DOI":"10.1016\/j.cellsig.2020.109524","article-title":"Role of oxygen and the HIF-pathway in polycystic kidney disease","volume":"69","author":"Buchholz","year":"2020","journal-title":"Cell Signal."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41581-019-0182-z","article-title":"Mechanisms of hypoxia signalling: New implications for nephrology","volume":"15","author":"Ratcliffe","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1200\/JCO.2012.45.2003","article-title":"Molecular genetics of clear-cell renal cell carcinoma","volume":"32","author":"Brugarolas","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Kim, E., and Zschiedrich, S. (2018). Renal cell carcinoma in von hippel\u2013lindau disease\u2014From tumor genetics to novel therapeutic strategies. Front. Pediatr., 6.","DOI":"10.3389\/fped.2018.00016"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4161\/cbt.10.7.13247","article-title":"Signaling pathways in renal cell carcinoma","volume":"10","author":"Banumathy","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: A metabolic disease","volume":"7","author":"Linehan","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.ki.5000221","article-title":"The VHL\/HIF oxygen-sensing pathway and its relevance to kidney disease","volume":"69","author":"Haase","year":"2006","journal-title":"Kidney Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1464-410X.1977.tb04076.x","article-title":"Polycystic renal disease--occurrence of malignant change and role of nephrectomy in potential transplant recipients","volume":"49","author":"Regan","year":"1977","journal-title":"Br. J. Urol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/j.gastro.2022.09.034","article-title":"Unfermented \u03b2-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease Patients","volume":"164","author":"Armstrong","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jmv.26461","article-title":"Targeting NLRP3 inflammasome in an animal model for Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","volume":"93","author":"Sergi","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Alipour, M., Lou, Y., Zimmerman, D., Bording-Jorgensen, M.W., Sergi, C., Liu, J.J., and Wine, E. (2013). A balanced IL-1beta activity is required for host response to Citrobacter rodentium infection. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080656"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00296-020-04683-5","article-title":"Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathies","volume":"41","author":"Cavalcante","year":"2021","journal-title":"Rheumatol. Int."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"155725","DOI":"10.1016\/j.cyto.2021.155725","article-title":"Serum NLRP3: A biomarker for identifying high-risk septic patients","volume":"149","author":"Huang","year":"2022","journal-title":"Cytokine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ymthe.2021.06.024","article-title":"The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: A potential therapeutic target","volume":"30","author":"Verma","year":"2022","journal-title":"Mol. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Tezcan, G., Garanina, E.E., Alsaadi, M., Gilazieva, Z.E., Martinova, E.V., Markelova, M.I., Arkhipova, S.S., Hamza, S., McIntyre, A., and Rizvanov, A.A. (2020). Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.607881"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"175126","DOI":"10.1016\/j.ejphar.2022.175126","article-title":"Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction","volume":"929","author":"Shen","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.4049\/jimmunol.2101154","article-title":"A Single Amino Acid Residue Defines the Difference in NLRP3 Inflammasome Activation between NEK7 and NEK6","volume":"208","author":"Jeltema","year":"2022","journal-title":"J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Sun, Z., Gong, W., Zhang, Y., and Jia, Z. (2020). Physiological and Pathological Roles of Mammalian NEK7. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.606996"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jaci.2022.05.029","article-title":"Spontaneous NLRP3 inflammasome-driven IL1-beta secretion is induced in severe COVID-19 patients and responds to anakinra treatment","volume":"4","author":"Bertoni","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/bloodadvances.2021005949","article-title":"Inflammasome activation in neutrophils of patients with severe COVID-19","volume":"6","author":"Aymonnier","year":"2022","journal-title":"Blood Adv."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Lopez-Rodriguez, A.B., Decouty-Perez, C., Farre-Alins, V., Palomino-Antolin, A., Narros-Fernandez, P., and Egea, J. (2022). Activation of NLRP3 Is Required for a Functional and Beneficial Microglia Response after Brain Trauma. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081550"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000510834","article-title":"Serum Copeptin, NLPR3, and suPAR Levels among Patients with Autosomal-Dominant Polycystic Kidney Disease with and without Impaired Renal Function","volume":"10","author":"Raptis","year":"2020","journal-title":"Cardiorenal Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fendo.2019.00093","article-title":"Insulin\/IGF-1R, SIRT1, and FOXOs Pathways-An Intriguing Interaction Platform for Bone and Osteosarcoma","volume":"10","author":"Sergi","year":"2019","journal-title":"Fron. Endocrinol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trsl.2019.02.006","article-title":"The double edge sword of fibrosis in cancer","volume":"209","author":"Chandler","year":"2019","journal-title":"Transl. Res."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Piersma, B., Hayward, M.K., and Weaver, V.M. (2020). Fibrosis and cancer: A strained relationship. Biochim. Biophys. Acta Rev. Cancer, 1873.","DOI":"10.1016\/j.bbcan.2020.188356"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1046\/j.1523-1755.2002.00374.x","article-title":"Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: A pathologic analysis","volume":"61","author":"Denton","year":"2002","journal-title":"Kidney Int."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00428-015-1833-5","article-title":"The medical autopsy as quality assurance tool in clinical medicine: Dreams and realities","volume":"468","author":"Wittekind","year":"2016","journal-title":"Virchows Arch."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Johnson Chacko, L., Wertjanz, D., Sergi, C., Dudas, J., Fischer, N., Eberharter, T., Hoermann, R., Glueckert, R., Fritsch, H., and Rask-Andersen, H. (2019). Growth and cellular patterning during fetal human inner ear development studied by a correlative imaging approach. BMC Dev. Biol., 19.","DOI":"10.1186\/s12861-019-0191-y"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Sergi, C., and Mikuz, G. (2008). External quality assurance as a revalidation method for pathologists in pediatric histopathology: Comparison of four international programs. BMC Clin. Pathol., 8.","DOI":"10.1186\/1472-6890-8-11"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/DHPS.S338050","article-title":"Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)","volume":"14","author":"Raina","year":"2022","journal-title":"Drug Healthc. Patient Saf."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3466.2007.00001.x","article-title":"Tolvaptan, an Orally Active Vasopressin V2-Receptor Antagonist\u2014Pharmacology and Clinical Trials","volume":"25","author":"Miyazaki","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.0000000000000022","article-title":"Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial","volume":"18","author":"Mekahli","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5414\/CN110510","article-title":"Tolvaptan vs. somatostatin in the treatment of ADPKD: A review of the literature","volume":"97","author":"Capuano","year":"2022","journal-title":"Clin. Nephrol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5049\/EBP.2022.20.1.10","article-title":"Practical Issues in the Management of Polycystic Kidney Disease: Blood Pressure and Water Balance","volume":"20","author":"Park","year":"2022","journal-title":"Electrolyte Blood Press."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Hallows, K.R., Li, H., Saitta, B., Sepehr, S., Huang, P., Pham, J., Wang, J., Mancino, V., Chung, E.J., and Pinkosky, S.L. (2022). Beneficial effects of bempedoic acid treatment in polycystic kidney disease cells and mice. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.1001941"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/3965\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:19:41Z","timestamp":1760030381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/3965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":100,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26093965"],"URL":"https:\/\/doi.org\/10.3390\/ijms26093965","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]}}}